Evidence map›Paper›PMID 31080449›Full record

ArticleFrontiers in immunology2019

LAIR-1 Limits Neutrophilic Airway Inflammation.

Kuldeep Kumawat, Ruben J Geerdink, Marije P Hennus, Mojtaba Abdul Roda, Ingrid van Ark, Thea Leusink-Muis, Gert Folkerts, Anita van Oort-Jansen, Alexandra Mazharian, Steve P Watson and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Inhibitory pattern recognition receptors.The Journal of experimental medicine · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Kuldeep KumawatLaboratory for Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Ruben J GeerdinkLaboratory for Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Marije P HennusDepartment of Pediatric Intensive Care, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
Mojtaba Abdul RodaDivision of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Ingrid van ArkDivision of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Thea Leusink-MuisDivision of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Gert FolkertsDivision of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Anita van Oort-JansenLaboratory for Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Alexandra MazharianCentre for Cardiovascular Sciences, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Steve P WatsonCentre for Cardiovascular Sciences, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Frank E CoenjaertsDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.
Louis BontLaboratory for Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Linde MeyaardLaboratory for Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
University Medical Center Utrecht · NLUtrecht University · NLUniversity of Birmingham · GB

Funding

British Heart Foundation FS/15/58/31784
6 · The paper itself

Abstract

Neutrophils are crucial to antimicrobial defense, but excessive neutrophilic inflammation induces immune pathology. The mechanisms by which neutrophils are regulated to prevent injury and preserve tissue homeostasis are not completely understood. We recently identified the collagen receptor leukocyte-associated immunoglobulin-like receptor (LAIR)-1 as a functional inhibitory receptor on airway-infiltrated neutrophils in viral bronchiolitis patients. In the current study, we sought to examine the role of LAIR-1 in regulating airway neutrophil responses

Indexed as

AnimalsBronchiolitis, ViralCell MovementChemokine CXCL1LungMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutNeutrophil InfiltrationNeutrophilsNicotianaPneumoniaReceptors, ImmunologicRespiratory Syncytial Virus, HumanChemokine CXCL1Cxcl1 protein, mouseleukocyte-associated immunoglobulin-like receptor 1Receptors, ImmunologicSmokeairwaybronchiolitiscigarette smokeinflammationLAIR-1neutrophilsRSV

Identifiers

PMID31080449
PMCPMC6497752
OpenAlexW2941441488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.